Additional Information

Description

Clonidine Transdermal System (TDS) at a dosage of 0.1 mg/day, packaged in 4 boxes, is a specialized form of medication delivery designed for sustained release through the skin. This system offers a convenient and consistent method of administering clonidine, a medication primarily used to treat hypertension (high blood pressure) and sometimes employed in managing certain withdrawal symptoms and conditions like attention deficit hyperactivity disorder (ADHD).

The transdermal patch delivers clonidine gradually over a 7-day period, adhering to the skin surface and allowing the medication to be absorbed directly into the bloodstream. This approach bypasses the gastrointestinal system, potentially reducing gastrointestinal side effects commonly associated with oral medications. The dosage strength of 0.1 mg/day is typically prescribed to achieve therapeutic blood levels sufficient for managing hypertension or other indicated conditions.

Each box contains multiple patches, ensuring a continuous supply for the prescribed treatment duration. The patches are designed for easy application and wear, providing patients with a discreet and comfortable method of medication delivery. This system requires adherence to proper skin preparation and rotation of application sites to optimize absorption and effectiveness.